natgillin/translations-raw huggingface dataset:
the person responsible for the placing on the market of a treated article treated with or incorporating PHMB (1415; 4.7) shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.
za proizvode, ki lahko povzročajo ostanke v živilih ali krmi, se preveri, ali je treba določiti nove ali spremeniti obstoječe mejne vrednosti ostankov (MRL) v skladu z Uredbo (ES) št. 470/2009 Evropskega parlamenta in Sveta ali Uredbo Evropskega parlamenta in Sveta (ES) št. 396/2005, in sprejmejo se vsi ustrezni ukrepi za zmanjšanje tveganja, da se veljavne mejne vrednosti ostankov ne presežejo.
The purity indicated in this column was the minimum degree of purity of the active substance evaluated.
proizvodi se ne vključijo v materiale in izdelke, namenjene za stik z živili v smislu člena 1(1) Uredbe (ES) št. 1935/2004, razen če je Komisija določila posebne mejne vrednosti o migraciji PHMB (1415; 4.7) v živila ali če je bilo v skladu z navedeno uredbo določeno, da takšne mejne vrednosti niso potrebne.
The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.
Oseba, odgovorna za dajanje na trg proizvoda, ki je bil tretiran s PHMB (1415; 4.7) ali pa ga vsebuje, zagotovi, da so na oznaki tretiranega izdelka navedene informacije iz drugega pododstavka člena 58(3) Uredbe (EU) št. 528/2012.
Commission Implementing Regulation (EU) 2018/614
Izvedbena uredba Komisije (EU) 2018/614
approving azoxystrobin as an active substance for use in biocidal products of product-types 7, 9 and 10
o odobritvi azoksistrobina kot aktivne snovi za uporabo v biocidnih proizvodih 7., 9. in 10. vrste proizvodov
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products, and in particular Article 9(1)(a) thereof,
ob upoštevanju Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta z dne 22. maja 2012 o dostopnosti na trgu in uporabi biocidnih proizvodov ter zlasti člena 9(1)(a) Uredbe,
The United Kingdom received on 13 April 2014 an application for the approval of the active substance azoxystrobin for use in biocidal products of product-type 7, film preservatives, product-type 9, fibre, leather, rubber and polymerised materials preservatives, and product-type 10, construction material preservatives, as described in Annex V to Regulation (EU) No 528/2012.
Združeno kraljestvo je 13. aprila 2014 prejelo vlogo za odobritev aktivne snovi azoksistrobin za uporabo v biocidnih proizvodih 7. vrste proizvodov (sredstva za zaščito (ohranitev) prevlek), 9. vrste proizvodov (proizvodi za zaščito vlaken, usnja, gume in polimeriziranih materialov) in 10. vrste proizvodov (sredstva za zaščito gradbenega materiala), kot so opredeljene v Prilogi V k Uredbi (EU) št. 528/2012.
The United Kingdom submitted the assessment reports together with its recommendations on 1 December 2016 in accordance with Article 8(1) of Regulation (EU) No 528/2012.
Združeno kraljestvo je 1. decembra 2016 v skladu s členom 8(1) Uredbe (EU) št. 528/2012 predložilo poročila o oceni skupaj s svojimi priporočili.
The opinions of the European Chemicals Agency were formulated on 3 October 2017 by the Biocidal Products Committee, having regard to the conclusions of the evaluating competent authority.
Odbor za biocidne pripravke je ob upoštevanju sklepov pristojnega ocenjevalnega organa 3. oktobra 2017 oblikoval mnenja Evropske agencije za kemikalije.
According to those opinions, biocidal products of product-types 7, 9 and 10 containing azoxystrobin may be expected to satisfy the criteria of Article 19(1)(b) of Regulation (EU) No 528/2012, provided that certain specifications and conditions concerning their use are complied with.
Iz navedenih mnenj je razvidno, da je za biocidne proizvode 7., 9. in 10. vrste proizvodov, ki vsebujejo azoksistrobin, mogoče pričakovati, da izpolnjujejo merila iz člena 19(1)(b) Uredbe (EU) št. 528/2012, če so izpolnjeni nekatere specifikacije in pogoji glede njihove uporabe.
It is therefore appropriate to approve azoxystrobin for use in biocidal products of product-types 7, 9 and 10, subject to compliance with certain specifications and conditions.
Zato je primerno azoksistrobin odobriti za uporabo v biocidnih proizvodih 7., 9. in 10. vrste proizvodov, če je ta v skladu z nekaterimi specifikacijami in pogoji.
The opinions conclude that azoxystrobin meets the criteria for being a very persistent (vP) and toxic (T) substance according to Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council.
Iz mnenj je razvidno, da azoksistrobin izpolnjuje merila za razvrstitev kot zelo obstojna (vP) in strupena (T) snov v skladu s Prilogo XIII k Uredbi (ES) št. 1907/2006 Evropskega parlamenta in Sveta.
Azoxystrobin therefore meets the conditions set out in point (d) of Article 10(1) of Regulation (EU) No 528/2012 and should be considered a candidate for substitution.
Azoksistrobin zato izpolnjuje pogoje, določene v točki (d) člena 10(1) Uredbe (EU) št. 528/2012, in bi ga bilo treba obravnavati kot možno snov za zamenjavo.
Pursuant to Article 10(4) of that Regulation, the approval of an active substance that is considered as a candidate for substitution should be for a period not exceeding 7 years.
V skladu s členom 10(4) navedene uredbe je treba odobritev aktivne snovi, ki se šteje kot možna snov za zamenjavo, podati za obdobje največ sedem let.
Since azoxystrobin meets the criteria for being very persistent (vP) according to Annex XIII to Regulation (EC) No 1907/2006, treated articles treated with or incorporating azoxystrobin should be appropriately labelled when placed on the market.
Ker azoksistrobin izpolnjuje kriterije za lastnost „zelo obstojen“ (vP – very peristent) v skladu s Prilogo XIII k Uredbi (ES) št. 1907/2006, bi bilo treba izdelke, ki so tretirani z azoksistrobinom ali ga vsebujejo, ustrezno označiti, ko se dajo na trg.
A reasonable period should be allowed to elapse before an active substance is approved in order to permit interested parties to take the preparatory measures necessary to meet the new requirements.
Pred odobritvijo aktivne snovi bi moralo biti na voljo ustrezno obdobje, v katerem bi zainteresirane strani lahko sprejele potrebne pripravljalne ukrepe za izpolnitev novih zahtev.
Azoxystrobin is approved as an active substance for use in biocidal products of product-types 7, 9 and 10, subject to the specifications and conditions set out in the Annex.
Azoksistrobin se odobri kot aktivna snov za uporabo v biocidnih proizvodih 7., 9. in 10. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).
Uredba (ES) št. 1907/2006 Evropskega parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH) ter o ustanovitvi Evropske agencije za kemikalije in o spremembi Direktive 1999/45/ES ter o razveljavitvi Uredbe Sveta (EGS) št. 793/93 in Uredbe Komisije (ES) št. 1488/94 ter Direktive Sveta 76/769/EGS in direktiv Komisije 91/155/EGS, 93/67/EGS, 93/105/ES in 2000/21/ES (UL L 396, 30.12.2006, str. 1).
Methyl(E)-2-2[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl-3-methoxyacrylate
metil(E)-2-2-[6-(2-cianofenoksi)pirimidin-4-iloksi]fenil-3-metoksiakrilat
CAS No: 131860-33-8
ES: ni na voljo
1 November 2018
Št.
Azoxystrobin is considered a candidate for substitution in accordance with point (d) of Article 10(1) of Regulation (EU) No 528/2012.
1. november 2018
The authorisations of biocidal products are subject to the following condition:
31. oktober 2025
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.
Azoksistrobin se šteje kot možna snov za zamenjavo v skladu s točko (d) člena 10(1) Uredbe (EU) št. 528/2012.
The placing on the market of treated articles is subject to the following condition:
Dovoljenja za biocidne proizvode se izdajo pod naslednjim pogojem:
The person responsible for the placing on the market of a treated article treated with or incorporating azoxystrobin shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.
Pri oceni proizvoda se posebna pozornost nameni vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki pa ni bila obravnavana v oceni tveganja aktivne snovi na ravni Unije.
Azoxystrobin is considered a candidate for substitution in accordance with Article 10(1)(d) of Regulation (EU) No 528/2012.
Za dajanje tretiranih izdelkov na trg velja naslednji pogoj:
The purity indicated in this column was the minimum degree of purity of the active substance evaluated.
Oseba, odgovorna za dajanje na trg izdelka, ki je tretiran s azoksistrobinom ali ga vsebuje, zagotovi, da so na oznaki navedenega tretiranega izdelka navedene informacije iz drugega pododstavka člena 58(3) Uredbe (EU) št. 528/2012.
The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.
Azoksistrobin se šteje kot možna snov za zamenjavo v skladu s členom 10(1)(d) Uredbe (EU) št. 528/2012.
supplementing Regulation (EU) 2017/1001 of the European Parliament and of the Council on the European Union trade mark, and repealing Delegated Regulation (EU) 2017/1430
o dopolnitvi Uredbe (EU) 2017/1001 Evropskega parlamenta in Sveta o blagovni znamki Evropske unije ter razveljavitvi Delegirane uredbe (EU) 2017/1430
Having regard to Regulation (EU) 2017/1001 of the European Parliament and of the Council of 14 June 2017 on the European Union trade mark, and in particular Article 48, Article 49(3), Article 65, Article 73, Article 96(4), Article 97(6), Article 98(5), Article 100(2), Article 101(5), Article 103(3), Article 106(3), Article 121, Article 168, Article 194(3) and Article 196(4) thereof,
ob upoštevanju Uredbe (EU) 2017/1001 Evropskega parlamenta in Sveta z dne 14. junija 2017 o blagovni znamki Evropske unije in zlasti člena 48, člena 49(3), členov 65, 73, členov 96(4), 97(6), 98(5), 100(2), 101(5), 103(3), 106(3), členov 121, 168 ter členov 194(3) in 196(4) Uredbe,
Council Regulation (EC) No 40/94, which was codified as Council Regulation (EC) No 207/2009, created a system specific to the Union for the protection of trade marks to be obtained at the level of the Union on the basis of an application to the European Union Intellectual Property Office (‘the Office’).
Z Uredbo Sveta (ES) št. 40/94, ki je bila kodificirana z Uredbo Sveta (ES) št. 207/2009, je bil uveden poseben sistem Unije, kjer se varstvo blagovne znamke na ravni Unije pridobi na podlagi prijave Uradu Evropske unije za intelektualno lastnino (v nadaljnjem besedilu: Urad).
Regulation (EU) 2015/2424 of the European Parliament and of the Council amending Regulation (EC) No 207/2009 aligned the powers conferred therein upon the Commission with Articles 290 and 291 of the Treaty on the Functioning of the European Union.
Uredba (EU) 2015/2424 Evropskega parlamenta in Sveta o spremembi Uredbe (ES) št. 207/2009 je uskladila pooblastila, ki se v navedeni uredbi prenesejo na Komisijo, s členoma 290 in 291 Pogodbe o delovanju Evropske unije.
In order to conform with the new legal framework resulting from that alignment, Commission Delegated Regulation (EU) 2017/1430 and Commission Implementing Regulation (EU) 2017/1431 were adopted.
Da se zagotovi skladnost z novim pravnim okvirom, ki je posledica navedene uskladitve, sta bili sprejeti Delegirana uredba Komisije (EU) 2017/1430 in Izvedbena uredba Komisije (EU) 2017/1431.
Regulation (EC) No 207/2009 was codified as Regulation (EU) 2017/1001.
Uredba (ES) št. 207/2009 je bila kodificirana z Uredbo (EU) 2017/1001.
For reasons of clarity and simplification, the references contained in a Delegated Regulation should reflect the renumbering of articles resulting from such a codification of the relevant basic act.
Zaradi jasnosti in poenostavitve bi morali sklici v Delegirani uredbi odražati preštevilčenje členov, ki so rezultat take kodifikacije zadevnega temeljnega akta.
Delegated Regulation (EU) 2017/1430 should therefore be repealed and the provisions of that Delegated Regulation should be laid down, with updated references to Regulation (EU) 2017/1001, in this Regulation.
Delegirano uredbo (EU) 2017/1430 bi bilo zato treba razveljaviti in določbe navedene delegirane uredbe v tej uredbi določiti s posodobljenimi sklici na Uredbo (EU) 2017/1001.
In order to enhance legal certainty and clarity, those opposition rules should take account of the extended relative grounds for refusal laid down in Regulation (EU) 2017/1001, in particular as regards the requirements for admissibility and substantiation of opposition proceedings, and be adjusted to better reflect the case-law of the Court of Justice of the European Union and to codify the practice of the Office.
Da se izboljša pravna varnost in jasnost, bi morala navedena pravila, ki urejajo ugovor, upoštevati razširjene relativne razloge za zavrnitev iz Uredbe (EU) 2017/1001, zlasti v zvezi z zahtevami glede dopustnosti in utemeljitve postopka z ugovorom, ter se prilagoditi tako, da bolje odražajo sodno prakso Sodišča Evropske unije in kodificirajo prakso Urada.
In order to allow for a more flexible, consistent and modern trade mark system in the Union, while ensuring legal certainty, it is appropriate to reduce the administrative burden for the parties in inter partes proceedings by relaxing the requirements for the substantiation of earlier rights in cases where the content of the relevant evidence is accessible online from a source recognised by the Office, as well as the requirement of submitting evidence in the language of the proceedings.
Da se skupaj s pravno varnostjo omogoči prožnejši, skladnejši in sodobnejši sistem blagovnih znamk v Uniji, je primerno zmanjšati upravno breme strank v postopkih inter partes tako, da se omilijo pogoji glede utemeljitve prejšnjih pravic, če je vsebina zadevnih dokazil dostopna prek spletnega vira, ki ga priznava Urad, ter zahteve za predložitev dokazil v jeziku postopka.
The procedural rules governing the revocation and declaration of invalidity of an EU trade mark should ensure that an EU trade mark can be revoked or declared invalid in an effective and efficient way by means of transparent, thorough, fair and equitable procedures.
Postopkovna pravila, ki urejajo razveljavitev in ugotovitev ničnosti znamk EU, bi morala zagotoviti pregleden, temeljit, pošten in pravičen postopek, s katerim je znamko EU mogoče razveljaviti ali razglasiti za nično na uspešen in učinkovit način.
For the sake of greater clarity, consistency as well as efficiency and legal certainty, the procedural rules governing the revocation and declaration of invalidity of an EU trade mark should be aligned with those applicable to opposition proceedings, retaining only those differences which are required due to the specific nature of revocation and declaration of invalidity proceedings.
Zaradi boljše jasnosti, skladnosti, učinkovitosti in pravne varnosti bi morala biti postopkovna pravila, ki urejajo razveljavitev in ugotovitev ničnosti znamk EU, usklajena s pravili, ki veljajo za postopke z ugovorom, ohraniti pa bi bilo treba le tiste razlike, ki so potrebne zaradi posebne narave postopkov za razveljavitev oziroma ugotovitev ničnosti.
According to settled case-law of the Court of Justice, unless otherwise provided, the Office enjoys discretionary powers when examining belated evidence, submitted for the purpose of either substantiating an opposition or proving genuine use of the earlier mark in the context of opposition or invalidity proceedings.
Urad ima v skladu z ustaljeno sodno prakso Sodišča, razen če je določeno drugače, v postopkih z ugovorom oziroma za ugotovitev ničnosti diskrecijske pravice pri preverjanju dokazil, predloženih z zamudo, katerih namen je utemeljitev ugovora ali dokazovanje resne in dejanske uporabe prejšnje znamke.
In order to allow for an effective, efficient and, within the scope of the appeal defined by the parties, complete review of decisions taken by the Office in the first instance by means of a transparent, thorough, fair and impartial appeal procedure suited to the specific nature of intellectual property law and taking into account the principles laid down in Regulation (EU) 2017/1001, it is appropriate to reinforce legal certainty and predictability by clarifying and specifying the procedural rules and the parties' procedural guarantees, in particular where a defendant makes use of the right to file a cross appeal.
Da se omogoči uspešna, učinkovita in – znotraj obsega pritožbe, kot jo določata stranki – celovita revizija odločb, ki jih je na prvi stopnji sprejel Urad po temeljitem, poštenem, pravičnem in nepristranskem pritožbenem postopku, prilagojenem posebni naravi prava intelektualne lastnine in načelom iz Uredbe (EU) 2017/1001, je zaradi večje pravne varnosti in predvidljivosti ustrezno pojasniti in opredeliti postopkovna pravila ter procesna jamstva strank, zlasti če tožena stranka uveljavlja pravico do nasprotne pritožbe.
In order to ensure an effective and efficient organisation of the Boards of Appeal, the President, the chairpersons and the members of the Boards of Appeal should, in the exercise of their respective functions conferred upon them by Regulation (EU) 2017/1001 and by this Regulation, be required to ensure a high quality and consistency of the decisions taken independently by the Boards on appeal as well as the efficiency of the appeal proceedings.
Predsednik, predsedujoči posameznim odborom in člani odborov za pritožbe bi morali biti pri opravljanju svojih nalog iz Uredbe (EU) 2017/1001 in te uredbe obvezani, da skupaj z visoko stopnjo kakovosti in skladnosti odločb, ki jih posamično sprejemajo odbori za pritožbe, zagotavljajo tudi učinkovitost pritožbenih postopkov in tako omogočijo uspešno in učinkovito organizacijo odborov za pritožbe.
In order to ensure the independence of the President, the chairpersons and the members of the Boards of Appeal as provided in Article 166 of Regulation (EU) 2017/1001, the Management Board should take the latter Article into account when adopting appropriate implementing rules to give effect to the Staff Regulations and the Conditions of Employment of Other Servants in accordance with Article 110 of the Staff Regulations.
Za zagotovitev neodvisnosti predsednika, predsedujočih in članov odborov za pritožbe, kot je določeno v členu 166 Uredbe (EU) 2017/1001, bi moral upravni odbor navedeni člen upoštevati pri sprejemanju ustreznih izvedbenih pravil za uveljavitev kadrovskih predpisov in pogojev za zaposlitev drugih uslužbencev v skladu s členom 110 Kadrovskih predpisov.
In order to enhance the transparency and predictability of the appeal proceedings, the rules of procedure of the Boards of Appeal originally laid down in Commission Regulation (EC) No 2868/95 and Commission Regulation (EC) No 216/96, should be set out in a single text and properly interlinked with the procedural rules applicable to the instances of the Office whose decisions are subject to appeals.
Da se okrepita preglednost in predvidljivost pritožbenih postopkov, bi se moral poslovnik odborov za pritožbe, prvotno določen v Uredbi Komisije (ES) št. 2868/95 in Uredbi Komisije (ES) št. 216/96, opredeliti v enem samem besedilu in primerno povezati s postopkovnimi pravili, ki veljajo za organe Urada, katerega odločbe so lahko predmeti pritožb.
Implementing Regulation (EU) 2017/1431 and Delegated Regulation (EU) 2017/1430 replaced the rules previously laid down in Regulations (EC) No 2868/95 and (EC) No 216/96 which were therefore repealed.
Izvedbena uredba (EU) 2017/1431 in Delegirana uredba (EU) 2017/1430 sta nadomestili pravila, prej določena v uredbah (ES) št. 2868/95 in (ES) št. 216/96, ki sta bili zato razveljavljeni.
Notwithstanding that repeal, it is necessary to continue to apply specific provisions of Regulations (EC) No 2868/95 and (EC) No 216/96 to certain proceedings that had been initiated before the date of applicability of Regulation (EU) 2017/1430 until the conclusion of those proceedings,
Ne glede na navedeno razveljavitev, je treba še naprej uporabljati posebne določbe uredb (ES) št. 2868/95 in (ES) št. 216/96 v nekaterih postopkih, začetih pred datumom začetka uporabe Uredbe (EU) 2017/1430, in sicer do konca teh postopkov –
the details of the procedure for filing and examining an opposition to the registration of an EU trade mark at the European Union Intellectual Property Office (‘the Office’);
podrobnosti postopka za vložitev in preizkus ugovora zoper registracijo blagovne znamke EU pri Uradu Evropske unije za intelektualno lastnino (v nadaljnjem besedilu: Urad);
the details of the procedure governing the amendment of an application for an EU trade mark;
podrobnosti postopka, ki ureja spremembe prijave blagovne znamke EU;
the details governing the revocation and declaration of invalidity of an EU trade mark, as well as the transfer of an EU trade mark registered in the name of an unauthorised agent;
podrobnosti, ki urejajo razveljavitev in ugotovitev ničnosti blagovne znamke EU ter prenos blagovne znamke EU, registrirane v imenu nepooblaščenega posrednika;
the formal content of a notice of appeal and the procedure for the filing and the examination of an appeal, the formal content and form of the Boards of Appeal's decisions and the reimbursement of the appeal fee, the details concerning the organisation of the Boards of Appeal, and the conditions under which decisions on appeals are to be taken by a single member;
formalne vsebine pritožb in postopka za vložitev ter preizkus pritožb, formalne vsebine in oblike odločb odborov za pritožbe ter povračila pristojbin za pritožbo, podrobnosti o organizaciji odborov za pritožbe ter pogoje, pod katerimi izda odločbe o pritožbah en sam član;
the detailed arrangements for oral proceedings and for the taking of evidence;
podrobnosti ureditev za ustne postopke in za pridobivanje dokazov;
the detailed arrangements for notification by the Office and the rules on the means of communication with the Office;
podrobnosti ureditev za obveščanje Urada in pravila o sredstvih za komunikacijo z Uradom;
the details regarding the calculation and duration of time limits;
podrobnosti o izračunu in trajanju časovnih rokov;
the procedure for the revocation of a decision or for the cancellation of an entry in the Register of EU trade marks;
postopka za razveljavitev odločbe ali za izbris vpisa iz registra blagovnih znamk EU;
the detailed arrangements for the resumption of proceedings before the Office;
podrobnosti ureditev za nadaljevanje postopka pred Uradom;
the conditions and the procedure for the appointment of a common representative, the conditions under which employees and professional representatives shall file an authorisation, and the content of that authorisation, and the circumstances in which a person may be removed from the list of admitted professional representatives;
pogojev in postopka za imenovanje skupnega zastopnika, pogojev, pod katerimi zaposleni in poklicni zastopniki vložijo pooblastilo, vsebine tega pooblastila ter okoliščin, v katerih je mogoče osebo odstraniti s seznama dovoljenih poklicnih zastopnikov;